Security record · archived quarter
MLTX
MoonLake Immunotherapeutics · Healthcare · Biotechnology
15Tracked holders
+2Δ holders
5.30MShares held
$38.02MReported value
+3New positions
−1Exits
Momentum inputs (comparable managers):
holder breadth +15.4% ·
share flow -30.0% ·
net new positions +13.3%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | +3 | 21.61M | $421.37M | +4 | −1 |
| Q1 2026 | 59 | +5 | 21.19M | $393.03M | +8 | −3 |
| Q4 2025 | 55 | +1 | 18.04M | $237.83M | +3 | −2 |
| Q3 2025 | 15 | +2 | 5.30M | $38.02M | +3 | −1 |
| Q2 2025 | 10 | -1 | 11.33M | $534.65M | +1 | −2 |
| Q1 2025 | 8 | 0 | 5.66M | $221.05M | +2 | −2 |
| Q4 2024 | 8 | 0 | 7.28M | $394.17M | +1 | −1 |
| Q3 2024 | 7 | 0 | 7.26M | $366.27M | — | — |
| Q2 2024 | 7 | — | 8.40M | $369.30M | — | — |
Who holds it · Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.50M | New | $10.76M | 0.0% | New | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 822.96K | -68.5% | $5.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 454.27K | New | $3.26M | 0.0% | New | 1 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 362.87K | — | $2.60M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | BlackRock ✦ (passive) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | The Vanguard Group ✦ (passive) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | The Vanguard Group ✦ (passive) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | The Vanguard Group ✦ (passive) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | The Vanguard Group ✦ (passive) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Millennium Management ✦ | 89.17K | New | $639,363 | 0.0% | New | 1 | SEC ↗ |
| 38 | Geode Capital Management ✦ (passive) | 62.38K | +4.8% | $447,008 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | State Street Global Advisors ✦ (passive) | 52.89K | -18.1% | $379,193 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 49.33K | -97.0% | $353,725 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Point72 Asset Management ✦ | 9.80K | -94.8% | $70,266 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $10.76M | 0.0% |
| Two Sigma Investments | $3.26M | 0.0% |
| Millennium Management | $639,363 | 0.0% |
Exited
| Wellington Management | $1.01M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 61.96M shares, $1.12B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2025 ·
Methodology ·
Get this via the API